On December 12, Diez-Canseco sold shares valued at $1,684,380, with the price per share ranging between $37.18 and $39.13. The following day, December 13, he sold additional shares for $3,147,302, with prices between $37.21 and $37.83 per share.In addition to these sales, Diez-Canseco acquired shares through stock option exercises, which amounted to $814,054, at prices between $3.6748 and $5.3286 per share.These transactions were made as part of a Rule 10b5-1 trading plan, which allows company insiders to set up a predetermined plan for buying or selling stocks. Following these transactions, Diez-Canseco retains a substantial holding in the company, with 660,330 shares remaining. The company has demonstrated strong fundamentals with 29% revenue growth and robust cash flows. Discover detailed insider trading patterns and comprehensive financial analysis through InvestingPro's exclusive research reports, available for 1,400+ US stocks. The company has demonstrated strong fundamentals with 29% revenue growth and robust cash flows. Discover detailed insider trading patterns and comprehensive financial analysis through InvestingPro's exclusive research reports, available for 1,400+ US stocks.
On December 12, Diez-Canseco sold shares valued at $1,684,380, with the price per share ranging between $37.18 and $39.13. The following day, December 13, he sold additional shares for $3,147,302, with prices between $37.21 and $37.83 per share.
In addition to these sales, Diez-Canseco acquired shares through stock option exercises, which amounted to $814,054, at prices between $3.6748 and $5.3286 per share.
These transactions were made as part of a Rule 10b5-1 trading plan, which allows company insiders to set up a predetermined plan for buying or selling stocks. Following these transactions, Diez-Canseco retains a substantial holding in the company, with 660,330 shares remaining.
In other recent news, Vital Farms experienced robust growth in its third-quarter net revenue, which saw a 31.3% increase to $145 million. The company's gross margin also climbed to 36.9% for the quarter, while the adjusted EBITDA rose by 64.5% to $15.2 million. Vital Farms aims to achieve $1 billion in net revenue by 2027, backed by strategic expansion plans including a new facility in Indiana.
Jefferies recently adjusted Vital Farms' stock target to $41.00 from $45.00, citing near-term challenges. Despite this, the firm maintains a Buy rating, expressing confidence in the company's long-term potential and its ability to navigate current constraints.
Additionally, Vital Farms' distribution points grew by 17.3% in the natural channel and 20.2% in the food channel, indicating an expanding distribution network. The company has also made significant executive hires, including Reena Van Hoven as Chief People Officer and Joe Holland as Chief Supply Chain Officer. Although the company anticipates slower fourth-quarter production growth due to maintenance, its updated revenue guidance for fiscal 2024 stands at least $600 million, reflecting a growth expectation of 27%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.